Table 3.
Effect of salidroside administration on antioxidant enzymes activities and MDA levels in liver in mice.
| Groups | Liver | |||
|---|---|---|---|---|
| SOD (U/mg protein) | GPx (U/mg protein) | CAT (U/mg protein) | MDA (nmol/mg protein) | |
| NC | 12.08 ± 2.19 b | 4.14 ± 0.54 b | 19.16 ± 2.81 b | 6.61 ± 0.47 b |
| DC | 6.16 ± 0.98 a | 1.12 ± 0.26 a | 11.43 ± 2.35 a | 9.27 ± 0.84 a |
| DLT, | 8.95 ± 1.17 a b | 3.47 ± 0.31 b | 15.60 ± 1.91 a b | 8.89 ± 0.58 a |
| DMT | 10.99 ± 1.64 b | 4.09 ± 0.48 b | 18.47 ± 2.13 b | 7.26 ± 0.67 b |
| DHT | 11.32 ± 2.25 b | 4.63 ± 0.41 b | 20.24 ± 1.68 b | 7.01 ± 0.49 b |
Data were presented as means ± SD. NC: normal control, DC: diabetic control; DLT: low dose salidroside (50 mg/kg) treatment, DMT: middle dose salidroside (100 mg/kg) treatment, DHT: high dose salidroside (200 mg/kg) treatment. a P < 0.05 as compared with the NC group; b P < 0.05 as compared with the DC group.